Code Snippets
curl "https://financialdata.net/api/v1/insider-transactions?identifier=GILD&key=API_KEY"import requests
url = 'https://financialdata.net/api/v1/insider-transactions?identifier=GILD&key=API_KEY'
response = requests.get(url)
print(response.json())
const url = 'https://financialdata.net/api/v1/insider-transactions?identifier=GILD&key=API_KEY';
const response = await fetch(url);
const data = await response.json();
console.log(data);
Sample Response
[
{
"trading_symbol": "GILD",
"central_index_key": "0000882095",
"registrant_name": "GILEAD SCIENCES, INC.",
"insider_name": "O'Day Daniel Patrick",
"insider_central_index_key": "0001638643",
"relationship_to_issuer": "Director, Chairman & CEO",
"is_derivatives_transaction": false,
"title_of_security": "Common Stock",
"transaction_date": "2026-10-01",
"transaction_code": "S",
"transaction_description": "Open market or private sale of non-derivative or derivative security",
"amount_of_securities": 12000,
"price_per_security": 147.719,
"acquired_or_disposed": "D",
"title_of_underlying_security": null,
"amount_of_underlying_securities": null,
"securities_owned_following_transaction": 569683,
"ownership_form": "D",
"nature_of_indirect_ownership": null
},
...
]Query Parameters
| Name | Type | Description |
|---|---|---|
| identifier | string | The trading symbol for a security, or the central index key (CIK). The latter is assigned to the entity by the United States Securities and Exchange Commission. (e.g., MSFT, 0000789019) |
| offset | integer | (Optional) The initial position of the record subset, which indicates how many records to skip. Defaults to 0. (e.g., 50) |
| format | string | (Optional) The format of the returned data, either JSON or CSV. Defaults to JSON. (e.g., json, csv) |
Endpoint Overview
Federal securities laws require insiders, including officials, directors, and those holding more than 10% of a company's securities, to report their purchases, sales, and holdings. The API endpoint gives comprehensive information about each of the transactions. The data is available for a few thousand US companies. There is a limit of 50 records per API call.
Company Profile
GILEAD SCIENCES, INC.
NASDAQ: GILD- Market Cap:$103.20B
- ISIN:US3755581036
- Fiscal Year End:12/31
- CEO:Daniel O'Day
- Employees:17000
Gilead Sciences, Inc. (/ˈɡɪliəd/) is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.
GILD Datasets
GILD Stock QuotesGILD Stock PricesGILD Minute PricesGILD Company InformationGILD Key MetricsGILD Market CapGILD Employee CountGILD Executive CompensationGILD Income StatementsGILD Balance Sheet StatementsGILD Cash Flow StatementsGILD Senate TradingGILD Institutional HoldingsGILD Analyst ConsensusGILD Earnings ReleasesGILD Stock SplitsGILD DividendsGILD Short Interest